Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Cyberliver Limited is currently navigating 1 pending office action in the Medical Devices & Mechanical Engineering technology area. This prosecution activity involves 1 distinct examiner and is situated within a single distinct art unit. The limited number of active matters indicates a highly focused or early-stage patent strategy. By operating within a single art unit, the company maintains a consistent technical environment for its current application, which can simplify the management of technical arguments and prior art disclosures.
The busiest examiner, PORTILLO, JAIRO H, is responsible for the sole pending office action. This action constitutes the total pending workload for the company. Practitioners should note that the entire current portfolio visibility is limited to this specific examiner's perspective. Since the busiest examiner pending count is also a single action, there is no internal benchmark for comparing examiner behavior or allowance rates within the company's own portfolio. This necessitates a deep dive into the examiner's history to anticipate potential hurdles.
The presence of a single examiner and art unit suggests that the company's intellectual property efforts are currently concentrated on a specific innovation. This lack of breadth in the current prosecution phase means that the entity's immediate patent goals are tied to a single set of office communications. Strategic focus on this matter is paramount for the company's current IP standing.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PORTILLO, JAIRO H | 1 | 53.4% | +30.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18717193 | SYSTEM AND COMPUTER METHOD INCLUDING A DIGITAL BIOMARKER (DBM), CLART, FOR REMOTELY ASSESSING HEPATIC ENCEPHALOPATHY FOR CIRROHTIC PATIENTS | PORTILLO, JAIRO H | 24d overdue |
| Art Unit | Apps |
|---|---|
| 3791 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18717193 | SYSTEM AND COMPUTER METHOD INCLUDING A DIGITAL BIOMARKER (DBM), CLART, FOR REMOTELY ASSESSING HEPATIC ENCEPHALOPATHY FOR CIRROHTIC PATIENTS | PORTILLO, JAIRO H | 3791 | §103 | Final Rejection | 24d overdue | Pending | Jun 06, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCyberliver Limited has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Jairo H Portillo has the most, with 1 of Cyberliver Limited's pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.